California Transplant Services Inc

Nonprofit profile at a glance

EIN
330632830
IRS 990 coverage
2014–2024
Forms available
Form 990 2024
Location
Carlsbad, CA, USA
Phone
7608046890
Rating
65
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Organ and Tissue Banks

Official website

Reported finances

Revenue
$2,584,979
Expenses
$1,435,535
Assets
$12,269,898
Liabilities
$818,471

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

4 people listed

Executive titles in this filing

  • DARYL LIRMAN CTBS (CEO)
  • MARC PABLO CEBT CTBS MICP (SR VICE PRESIDENT)

Highest reported compensation

  • MARC PABLO CEBT CTBS MICP (SR VICE PRESIDENT): $326,839 total reported compensation
  • DARYL LIRMAN CTBS (CEO): $325,517 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

To act as a responsible steward on behalf of our community of anatomical donations that are gifted for transplant and research; gifts that are given selflessly by very special people so others may enjoy a longer and better quality of life.

What it reported doing in 2024

100% of program service revenue excluding investment income for 2024 was received from fees for services related to eye and tissue banking activities. Cts distributes ocular tissue for sight restorative surgeries. Ocular tissue cts distributes is recovered and processed by eye banks that are registered with the fda & members of the eye bank association of america. Cts is a national repository of autologous cranial bone flaps recovered from living patients during medical and traumatic surgical procedures for reimplantation at a later time. Cts provides hospital in-service education, hospital staff training, documentation, cryogenic storage, and autologous, documented chain of custody inter-facility tissue transfer services in validated containers following procedures as mandated by the fda. Cts is registered with, and subject to the regulatory authority of the us food and drug administration for the distribution and storage of human allograft and autologous tissue. Cts is licensed as a tissue bank by the state of California department of health, is a member of the eye bank association of america, and is an accredited institutional member of the american association of tissue banks.

Operating model

Revenue model
Earned-program. 85% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - The filed numbers largely add up and most filed governance safeguards are in place. A relatively small share of available resources goes toward mission work and a relatively small share of voting board members are independent.

Rating breakdown

  • Financial Efficiency: 53
  • Transparency & Controls: 82
  • Accountability: 60
  • Sustainability: 77
  • Growth: 60

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 42.9%; rating input score 43
  • Program expense ratio: 87.8%; rating input score 88
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: 4 of 6 controls in place; rating input score 67
    • Compensation committee: Pass
    • Independent consultant: Missing
    • Other Form 990s reviewed: Pass
    • Written employment contract: Missing
    • Compensation survey or study: Pass
    • Board or committee approval: Pass
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 50%; rating input score 50; 8th percentile among comparable filings
  • Governance controls: 6 of 8 controls in place; rating input score 75
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Pass
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 44.5%; rating input score 90; 90th percentile among comparable filings
  • Total-asset coverage ratio: 8.55; rating input score 89; 89th percentile among comparable filings
  • Liabilities to assets ratio: 0.07; rating input score 66; 66th percentile among comparable filings
  • Officer compensation ratio: 45.4%; rating input score 2; 2nd percentile among comparable filings

Growth

  • Program expense growth: -3.7% per year; rating input score 0; 6th percentile among comparable filings
  • Revenue growth: 0.2% per year; rating input score 100; 12th percentile among comparable filings
  • Asset growth: 7.4% per year; rating input score 100; 47th percentile among comparable filings

Details

  • Where the money goes: 42.9% of revenue deployed · 87.8% of spending went to programs
  • Governance: 2 of 4 board members independent · 6 of 8 filing controls reported
  • Programs: 1 filed program accomplishment · $1.3M in reported program spending
  • Leadership: top reported pay $327K · 4 people listed · 4 of 6 pay-setting controls reported
  • Consistency: 28 of 28 current checks pass
  • Schedules: 4 filed schedules · includes executive pay
  • Filing history: 10 filing years from 2014 to 2024
  • Contacts: How to reach this organization
  • Money network: 2 filed money-flow records
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Moderate — Financial Efficiency: Mission deployment rate scored 43/100.
  • Review — Accountability: Independent voting board scored 50/100.
  • High — Growth: Program expense growth scored 0/100.
  • Review — Accountability: Governance controls: Independent financial-statement audit not reported.
  • High — Sustainability: Officer compensation ratio scored 2/100.